FDA Approved: ICOSAPENT ETHYL — Original Application (Vitruvias Therapeutics, Inc.)

View source ↗

Summary

FDA approved the original application for ICOSAPENT ETHYL by Vitruvias Therapeutics, Inc., enabling a generic version of the triglyceride-lowering therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypertriglyceridemia

Drugs mentioned

• ICOSAPENT ETHYL (icosapent ethyl)

Snippet

ORIG AP for ICOSAPENT ETHYL (ICOSAPENT ETHYL)